Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cronos Group Inc. (CRON:NASDAQ), powered by AI.
Cronos Group Inc. is currently trading at $2.53. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cronos Group Inc. on Alpha Lenz.
Cronos Group Inc.'s P/E ratio is 23.5.
“Cronos Group Inc. trades at a P/E of 23.5 (fair value) with modest ROE of 3.8%. 3Y revenue CAGR of 22.1% highlights clear growth momentum.”
Ask for details →Cronos Group Inc. is a vertically integrated cannabis company that engages in the cultivation, manufacturing, and distribution of cannabis and related products. Its primary focus is on producing and selling cannabis flower, oils, and derivative products for recreational and medicinal purposes. The company's operations span across different international markets, leveraging strategic partnerships to expand its footprint and influence in the rapidly evolving cannabis industry. Cronos Group is known for investing in research and development to advance cannabinoid innovation and enhance its product offerings. It not only addresses consumer needs through various brands but also aims to comply with stringent regulatory frameworks in the regions it serves. As an active participant in the cannabis sector, Cronos Group plays a crucial role in shaping industry standards and responding to changing market dynamics. With an emphasis on sustainability and corporate responsibility, Cronos contributes to the broader acceptance and understanding of cannabis as a major component of the health and wellness market.
“Cronos Group Inc. trades at a P/E of 23.5 (fair value) with modest ROE of 3.8%. 3Y revenue CAGR of 22.1% highlights clear growth momentum.”
Ask for details →